Minimal residual disease in acute leukaemia: preclinical studies in a relevant rat model (BNML)-Reference-Cited by-同舟云学术

Minimal residual disease in acute leukaemia: preclinical studies in a relevant rat model (BNML)

Published:1991-06 Issue:3 Volume:4 Page:609-635
ISSN:0950-3536
Container-title:Baillière's Clinical Haematology
language:en
Short-container-title:Baillière's Clinical Haematology

Author:

Hagenbeek Anton,Martens Anton C.M.

Publisher

Elsevier BV

Subject

Hematology

Reference53 articles.

1. Relevance of recruitment-synchronization in the scheduling of 1-beta-D-arabino-furanosylcytosine in a slow growing acute myeloid leukemia in the rat;Aglietta;Cancer Research,1979

2. The relevance of cell cycle kinetics for optimal scheduling of 1-β-D-arabino-furanosylcytosine and methotrexate in a slow growing acute myeloid leukemia (BNML);Aglietta;Cancer Chemotherapy and Pharmacology,1978

3. Bivariate flow karyotyping of acute myelocytic leukemia in the BNML rat model;Arkesteijn;Cytometry,1987

4. Bivariate flow karyotyping in human Philadelphia positive chronic myelocytic leukemia;Arkesteijn;Blood,1988

5. Clinical applications of flow karyotyping in myelocytic leukemia by stimulation of different subpopulations of cells in blood or bone marrow samples;Arkesteijn;Cytometry,1990

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current assessment and management of measurable residual disease in patients with acute lymphoblastic leukemia in the setting of CAR-T-cell therapy;Chinese Medical Journal;2023-12-26

2. Measurable residual disease testing in acute myeloid leukaemia;Leukemia;2017-04-07

3. Physiologically based toxicokinetic modeling of secondary acute myelolytic leukemia;Environmental Toxicology and Pharmacology;2014-01

4. Animal models of acute myelogenous leukaemia – development, application and future perspectives;Leukemia;2005-03-10

5. Multidimensional Flow Cytometry for Detection of Minimal Residual Disease in Acute Myeloid Leukemia;Leukemia & Lymphoma;2003-01